Butallylonal
From Wikipedia, the free encyclopedia
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
5-sec-Butyl-5-(beta-bromoallyl)barbituric acid
|
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | 1142-70-7  |
| ATC code | none |
| PubChem | CID 14362 |
| ChemSpider | 13723 |
| ChEMBL | CHEMBL469253 |
| Chemical data | |
| Formula | C11H15BrN2O3 |
| Molar mass | 303.15 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
| (verify) | |
Butallylonal is a barbiturate derivative invented in the 1920s.[1] It has sedative properties, and was used primarily as an anaesthetic in veterinary medicine.[2] Butallylonal is considered similar in effects to pentobarbital but is longer in action, being considered an intermediate-acting barbiturate rather than short-acting.
References[edit]
- ^ US 1739662
- ^ Mittmann U, Schmidt HD, Schmier J, Wirth RH (1976). "Hemorrhagic shock with fixed hypotension and with spontaneous recovery of blood pressure. A comparison of two shock models". Basic Research in Cardiology. 71 (1): 47–59. doi:10.1007/BF01907782. PMID 1259685.
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
